Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Genitourinary 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Prostatic Neoplasms 1Locally Advanced or Metastatic Unresectable Urothelial Cancer 1

Interventions

Specimen Handling 71Magnetic Resonance Spectroscopy 57Biopsy 44pembrolizumab 38Carboplatin 32Nivolumab 29Cyclophosphamide 27Radiotherapy 26Radiation 25Paclitaxel 24Cisplatin 24olaparib 21Etoposide 19Doxorubicin 18durvalumab 17Taxes 17Radiotherapy, Intensity-Modulated 17Dexamethasone 17Bevacizumab 17X-Rays 16Vincristine 16Prednisone 16Immunoglobulin G 16Disulfides 16Cytarabine 15Platinum 14Leucovorin 14Docetaxel 14Pemetrexed 13Lenalidomide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × sacituzumab govitecan × 30 days × Clear all
NCT03725761 2026-06-04

Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy

University of Wisconsin, Madison

Phase 2 Active not recruiting
31 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT04527991 2026-06-02

TROPiCS-04

Gilead Sciences

Phase 3 Completed
711 enrolled 25 charts
Genitourinary

Locally Advanced or Metastatic Unresectable Urothelial Cancer

NCT03337698 2026-05-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Terminated
314 enrolled 31 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05089734 2026-05-07

EVOKE-01

Gilead Sciences

Phase 3 Active not recruiting
603 enrolled 20 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡